We are live on ! Find out more
FCM

Frontier Capital Management Portfolio holdings

AUM $10.7B
1-Year Est. Return 67.78%
This Fund
S&P 500
This Quarter Est. Return
-3%
1 Year Est. Return
+67.78%
3 Year Est. Return
+183.84%
5 Year Est. Return
+266.8%
10 Year Est. Return
+1,486.88%
AUM
$12.4B
AUM Growth
-$1.17B
Cap. Flow
-$425M
Cap. Flow %
-3.42%
Top 10 Hldgs %
13.34%
Holding
358
New
14
Increased
143
Reduced
171
Closed
11

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$83.7M
2
HUM icon
Humana
HUM
+$52.3M
3
QLGC
QLOGIC CORP
QLGC
+$49.1M
4
DBI icon
Designer Brands
DBI
+$45.5M
5
PBYI icon
Puma Biotechnology
PBYI
+$43M

Sector Composition

Rank Sector Weight
1 Technology 19.83%
2 Industrials 19.14%
3 Healthcare 12.21%
4 Financials 11.95%
5 Consumer Discretionary 10.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
301
AbbVie
ABBV
$454B
$3.07M 0.02%
53,146
+630
+1% +$35K
P
302
DELISTED
Pandora Media Inc
P
$2.72M 0.02%
112,478
+103,229
+1,116% +$2.74M
TEVA icon
303
Teva Pharmaceuticals
TEVA
$45.1B
$2.64M 0.02%
49,086
+560
+1% +$29.7K
GNC
304
DELISTED
GNC Holdings, Inc.
GNC
$2.44M 0.02%
62,882
-5,743
-8% -$209K
NSP icon
305
Insperity
NSP
$1.9B
$2.17M 0.02%
158,542
-1,657,974
-91% -$25.2M
IL
306
DELISTED
IntraLinks Holdings Inc.
IL
$2.08M 0.02%
256,514
-83,506
-25% -$702K
XONE
307
DELISTED
The ExOne Company
XONE
$1.83M 0.01%
87,569
-197,133
-69% -$6.02M
XENT
308
DELISTED
Intersect ENT, Inc
XENT
$1.65M 0.01%
+106,590
New +$1.6M
ELOS
309
DELISTED
Syneron Medical Ltd
ELOS
$1.46M 0.01%
145,511
-60,839
-29% -$619K
SEAC
310
DELISTED
Seachange International Inc
SEAC
$552K ﹤0.01%
3,967
-15
-0.4% -$2.28K
RTI
311
DELISTED
RTI INTL METALS INC(HLDG CO)
RTI
$504K ﹤0.01%
20,427
-156,275
-88% -$4.23M
RMAX
312
DELISTED
RE/MAX Holdings
RMAX
$500K ﹤0.01%
16,819
-168
-1% -$5K
APTV icon
313
Aptiv
APTV
$9.3B
$283K ﹤0.01%
4,607
-1,198,840
-100% -$82.1M
SGEN
314
DELISTED
Seagen Inc. Common Stock
SGEN
$215K ﹤0.01%
5,789
-149
-3% -$5.86K
FIS icon
315
Fidelity National Information Services
FIS
$19.7B
$50K ﹤0.01%
886
QVCGA
316
DELISTED
QVC Group Inc Series A
QVCGA
$44K ﹤0.01%
37
WY icon
317
Weyerhaeuser
WY
$16B
$41K ﹤0.01%
1,294
-5,358
-81% -$176K
DVA icon
318
DaVita
DVA
$11.6B
$36K ﹤0.01%
494
MU icon
319
Micron Technology
MU
$1.04T
$35K ﹤0.01%
1,010
CI icon
320
Cigna
CI
$74.2B
$34K ﹤0.01%
371
RLJ icon
321
RLJ Lodging Trust
RLJ
$1.66B
$34K ﹤0.01%
1,188
AWK icon
322
American Water Works
AWK
$27.4B
$33K ﹤0.01%
679
+90
+15% +$4.4K
EIX icon
323
Edison International
EIX
$21.6B
$32K ﹤0.01%
580
MFA
324
MFA Financial
MFA
$865M
$32K ﹤0.01%
1,031
EPAC icon
325
Enerpac Tool Group
EPAC
$1.8B
$31K ﹤0.01%
1,020
+210
+26% +$6.94K

Similar funds

Frontier Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Frontier Capital Management held 358 positions worth $12.4B, down 8.6% from $13.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Frontier Capital Management withdrew a net $425M in Q3 2014, closing 11 positions and reducing 171 holdings. Its most notable exit was INTERMUNE INC, an estimated $57.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Frontier Capital Management opened a new position in Humana worth $53.6M.

  • Frontier Capital Management's largest Q3 2014 buy was Humana: 411,770 shares worth $53.6M.
  • Frontier Capital Management added most to Centene in Q3 2014, an estimated $83.7M increase.
  • Frontier Capital Management's biggest Q3 2014 reduction was Allergan plc, cutting an estimated $104M.
  • Frontier Capital Management fully exited INTERMUNE INC in Q3 2014, selling an estimated $57.5M.
  • Frontier Capital Management's ten largest holdings make up 13% of its $12.4B portfolio in Q3 2014.
  • Frontier Capital Management opened 14 new positions and closed 11 in Q3 2014.
  • Frontier Capital Management's portfolio value fell 8.6% quarter-over-quarter to $12.4B.

Based on Frontier Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.